Hanseatic Management Services’s Impax Laboratories, Inc. IPXL Stock Holding History

Hanseatic Management Services’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-37	Closed	-$1K	–	504
2018 Q1	$1K	Hold	37	–	–	﹤0.01%	434
2017 Q4	$1K	Sell	37 -20	-35%	-$367	﹤0.01%	426
2017 Q3	$1K	Buy	+57	New	+$1.09K	﹤0.01%	412
2015 Q4	–	Sell	-23,062	Closed	-$812K	–	434
2015 Q3	$812K	Buy	23,062 +5,506	+31%	+$248K	0.25%	131
2015 Q2	$806K	Buy	17,556 +9,392	+115%	+$446K	0.36%	103
2015 Q1	$383K	Buy	+8,164	New	+$325K	0.2%	123

Hanseatic Management Services's IPXL Position: Q2 2018 in Review

Hanseatic Management Services sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 37 shares — an estimated $1K sold.

Hanseatic Management Services first reported a position in IPXL in Q1 2015 and held it in 6 quarters. The position peaked at $812K in Q3 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Hanseatic Management Services reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Hanseatic Management Services sold 37 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1K.
Hanseatic Management Services first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 6 quarters.
Hanseatic Management Services's Impax Laboratories, Inc. position peaked at $812K in Q3 2015.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Hanseatic Management Services's 13F filing for Q2 2018, filed 14 Aug 2018.